Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: A0A3Q8IAC7
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006206 | pyrimidine nucleobase metabolic process | 5 | 11 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 7 | 11 |
GO:0006220 | pyrimidine nucleotide metabolic process | 5 | 11 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 6 | 11 |
GO:0006222 | UMP biosynthetic process | 8 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 11 |
GO:0006793 | phosphorus metabolic process | 3 | 11 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009058 | biosynthetic process | 2 | 11 |
GO:0009112 | nucleobase metabolic process | 4 | 11 |
GO:0009117 | nucleotide metabolic process | 5 | 11 |
GO:0009123 | nucleoside monophosphate metabolic process | 5 | 11 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 6 | 11 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 6 | 11 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 7 | 11 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 7 | 11 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 6 | 11 |
GO:0009165 | nucleotide biosynthetic process | 6 | 11 |
GO:0009173 | pyrimidine ribonucleoside monophosphate metabolic process | 7 | 11 |
GO:0009174 | pyrimidine ribonucleoside monophosphate biosynthetic process | 8 | 11 |
GO:0009218 | pyrimidine ribonucleotide metabolic process | 6 | 11 |
GO:0009220 | pyrimidine ribonucleotide biosynthetic process | 7 | 11 |
GO:0009259 | ribonucleotide metabolic process | 5 | 11 |
GO:0009260 | ribonucleotide biosynthetic process | 6 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0018130 | heterocycle biosynthetic process | 4 | 11 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 11 |
GO:0019637 | organophosphate metabolic process | 3 | 11 |
GO:0019693 | ribose phosphate metabolic process | 4 | 11 |
GO:0019856 | pyrimidine nucleobase biosynthetic process | 6 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 11 |
GO:0044205 | 'de novo' UMP biosynthetic process | 9 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044249 | cellular biosynthetic process | 3 | 11 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 11 |
GO:0044281 | small molecule metabolic process | 2 | 11 |
GO:0046049 | UMP metabolic process | 7 | 11 |
GO:0046112 | nucleobase biosynthetic process | 5 | 11 |
GO:0046390 | ribose phosphate biosynthetic process | 5 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0072527 | pyrimidine-containing compound metabolic process | 4 | 11 |
GO:0072528 | pyrimidine-containing compound biosynthetic process | 5 | 11 |
GO:0090407 | organophosphate biosynthetic process | 4 | 11 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 11 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 11 |
GO:1901293 | nucleoside phosphate biosynthetic process | 5 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 11 |
GO:1901576 | organic substance biosynthetic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004588 | orotate phosphoribosyltransferase activity | 5 | 11 |
GO:0004590 | orotidine-5'-phosphate decarboxylase activity | 5 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0016757 | glycosyltransferase activity | 3 | 11 |
GO:0016763 | pentosyltransferase activity | 4 | 11 |
GO:0016829 | lyase activity | 2 | 11 |
GO:0016830 | carbon-carbon lyase activity | 3 | 11 |
GO:0016831 | carboxy-lyase activity | 4 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 90 | 94 | PF00656 | 0.373 |
CLV_NRD_NRD_1 | 291 | 293 | PF00675 | 0.352 |
CLV_NRD_NRD_1 | 345 | 347 | PF00675 | 0.247 |
CLV_NRD_NRD_1 | 431 | 433 | PF00675 | 0.484 |
CLV_PCSK_FUR_1 | 10 | 14 | PF00082 | 0.422 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.485 |
CLV_PCSK_KEX2_1 | 291 | 293 | PF00082 | 0.352 |
CLV_PCSK_KEX2_1 | 345 | 347 | PF00082 | 0.247 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.341 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.300 |
CLV_PCSK_PC1ET2_1 | 12 | 14 | PF00082 | 0.485 |
CLV_PCSK_PC1ET2_1 | 35 | 37 | PF00082 | 0.341 |
CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.300 |
CLV_PCSK_SKI1_1 | 128 | 132 | PF00082 | 0.300 |
CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 252 | 256 | PF00082 | 0.549 |
CLV_PCSK_SKI1_1 | 292 | 296 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 346 | 350 | PF00082 | 0.261 |
CLV_PCSK_SKI1_1 | 408 | 412 | PF00082 | 0.397 |
CLV_PCSK_SKI1_1 | 446 | 450 | PF00082 | 0.435 |
DOC_MAPK_gen_1 | 10 | 20 | PF00069 | 0.301 |
DOC_MAPK_gen_1 | 188 | 196 | PF00069 | 0.343 |
DOC_MAPK_gen_1 | 252 | 261 | PF00069 | 0.525 |
DOC_MAPK_gen_1 | 279 | 288 | PF00069 | 0.386 |
DOC_MAPK_gen_1 | 362 | 370 | PF00069 | 0.498 |
DOC_MAPK_gen_1 | 386 | 394 | PF00069 | 0.441 |
DOC_MAPK_MEF2A_6 | 12 | 20 | PF00069 | 0.300 |
DOC_MAPK_MEF2A_6 | 188 | 196 | PF00069 | 0.289 |
DOC_MAPK_MEF2A_6 | 282 | 290 | PF00069 | 0.355 |
DOC_PP4_FxxP_1 | 196 | 199 | PF00568 | 0.319 |
DOC_USP7_MATH_1 | 11 | 15 | PF00917 | 0.499 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.343 |
DOC_USP7_MATH_1 | 328 | 332 | PF00917 | 0.527 |
DOC_USP7_MATH_1 | 436 | 440 | PF00917 | 0.529 |
DOC_USP7_UBL2_3 | 135 | 139 | PF12436 | 0.310 |
DOC_WW_Pin1_4 | 108 | 113 | PF00397 | 0.319 |
DOC_WW_Pin1_4 | 281 | 286 | PF00397 | 0.361 |
LIG_14-3-3_CanoR_1 | 10 | 16 | PF00244 | 0.346 |
LIG_14-3-3_CanoR_1 | 23 | 31 | PF00244 | 0.300 |
LIG_14-3-3_CanoR_1 | 291 | 297 | PF00244 | 0.367 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.405 |
LIG_FHA_1 | 177 | 183 | PF00498 | 0.343 |
LIG_FHA_2 | 377 | 383 | PF00498 | 0.455 |
LIG_GBD_Chelix_1 | 329 | 337 | PF00786 | 0.261 |
LIG_Integrin_RGD_1 | 85 | 87 | PF01839 | 0.300 |
LIG_LIR_Apic_2 | 193 | 199 | PF02991 | 0.319 |
LIG_LIR_Gen_1 | 2 | 11 | PF02991 | 0.340 |
LIG_LIR_Gen_1 | 284 | 294 | PF02991 | 0.349 |
LIG_LIR_Gen_1 | 306 | 314 | PF02991 | 0.458 |
LIG_LIR_Gen_1 | 417 | 424 | PF02991 | 0.411 |
LIG_LIR_Gen_1 | 61 | 70 | PF02991 | 0.343 |
LIG_LIR_Nem_3 | 193 | 198 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.334 |
LIG_LIR_Nem_3 | 284 | 290 | PF02991 | 0.341 |
LIG_LIR_Nem_3 | 295 | 299 | PF02991 | 0.300 |
LIG_LIR_Nem_3 | 306 | 310 | PF02991 | 0.417 |
LIG_LIR_Nem_3 | 417 | 421 | PF02991 | 0.422 |
LIG_LIR_Nem_3 | 61 | 66 | PF02991 | 0.320 |
LIG_LIR_Nem_3 | 97 | 103 | PF02991 | 0.291 |
LIG_LYPXL_yS_3 | 296 | 299 | PF13949 | 0.412 |
LIG_PDZ_Class_1 | 452 | 457 | PF00595 | 0.497 |
LIG_Pex14_2 | 448 | 452 | PF04695 | 0.501 |
LIG_Pex14_2 | 54 | 58 | PF04695 | 0.300 |
LIG_SH2_CRK | 307 | 311 | PF00017 | 0.447 |
LIG_SH2_CRK | 324 | 328 | PF00017 | 0.447 |
LIG_SH2_NCK_1 | 155 | 159 | PF00017 | 0.319 |
LIG_SH2_NCK_1 | 44 | 48 | PF00017 | 0.300 |
LIG_SH2_PTP2 | 287 | 290 | PF00017 | 0.387 |
LIG_SH2_STAP1 | 155 | 159 | PF00017 | 0.319 |
LIG_SH2_STAP1 | 307 | 311 | PF00017 | 0.447 |
LIG_SH2_STAP1 | 416 | 420 | PF00017 | 0.398 |
LIG_SH2_STAP1 | 44 | 48 | PF00017 | 0.284 |
LIG_SH2_STAP1 | 95 | 99 | PF00017 | 0.300 |
LIG_SH2_STAT5 | 153 | 156 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 287 | 290 | PF00017 | 0.345 |
LIG_SH3_3 | 291 | 297 | PF00018 | 0.367 |
LIG_SUMO_SIM_anti_2 | 365 | 372 | PF11976 | 0.447 |
LIG_SUMO_SIM_anti_2 | 393 | 399 | PF11976 | 0.484 |
LIG_SUMO_SIM_par_1 | 365 | 372 | PF11976 | 0.447 |
LIG_SUMO_SIM_par_1 | 396 | 402 | PF11976 | 0.447 |
LIG_SUMO_SIM_par_1 | 77 | 82 | PF11976 | 0.301 |
LIG_TRAF2_1 | 30 | 33 | PF00917 | 0.307 |
LIG_TRAF2_1 | 439 | 442 | PF00917 | 0.494 |
LIG_TYR_ITIM | 294 | 299 | PF00017 | 0.483 |
LIG_TYR_ITIM | 322 | 327 | PF00017 | 0.300 |
LIG_UBA3_1 | 427 | 433 | PF00899 | 0.524 |
MOD_CK1_1 | 280 | 286 | PF00069 | 0.423 |
MOD_CK1_1 | 331 | 337 | PF00069 | 0.412 |
MOD_CK2_1 | 372 | 378 | PF00069 | 0.300 |
MOD_CK2_1 | 436 | 442 | PF00069 | 0.505 |
MOD_GlcNHglycan | 219 | 223 | PF01048 | 0.319 |
MOD_GlcNHglycan | 279 | 282 | PF01048 | 0.452 |
MOD_GlcNHglycan | 330 | 333 | PF01048 | 0.445 |
MOD_GlcNHglycan | 388 | 391 | PF01048 | 0.343 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.300 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.299 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.412 |
MOD_GSK3_1 | 277 | 284 | PF00069 | 0.424 |
MOD_GSK3_1 | 372 | 379 | PF00069 | 0.295 |
MOD_GSK3_1 | 431 | 438 | PF00069 | 0.429 |
MOD_N-GLC_1 | 225 | 230 | PF02516 | 0.300 |
MOD_N-GLC_1 | 274 | 279 | PF02516 | 0.502 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.308 |
MOD_NEK2_1 | 265 | 270 | PF00069 | 0.354 |
MOD_NEK2_2 | 274 | 279 | PF00069 | 0.405 |
MOD_PIKK_1 | 436 | 442 | PF00454 | 0.507 |
MOD_PK_1 | 255 | 261 | PF00069 | 0.526 |
MOD_PKA_2 | 431 | 437 | PF00069 | 0.454 |
MOD_PKB_1 | 188 | 196 | PF00069 | 0.343 |
MOD_Plk_1 | 274 | 280 | PF00069 | 0.511 |
MOD_Plk_4 | 190 | 196 | PF00069 | 0.300 |
MOD_Plk_4 | 295 | 301 | PF00069 | 0.239 |
MOD_Plk_4 | 393 | 399 | PF00069 | 0.343 |
MOD_ProDKin_1 | 108 | 114 | PF00069 | 0.319 |
MOD_ProDKin_1 | 281 | 287 | PF00069 | 0.362 |
MOD_SUMO_rev_2 | 32 | 37 | PF00179 | 0.398 |
MOD_SUMO_rev_2 | 372 | 381 | PF00179 | 0.300 |
TRG_DiLeu_BaEn_1 | 33 | 38 | PF01217 | 0.319 |
TRG_DiLeu_BaLyEn_6 | 337 | 342 | PF01217 | 0.319 |
TRG_DiLeu_LyEn_5 | 33 | 38 | PF01217 | 0.307 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.319 |
TRG_ENDOCYTIC_2 | 287 | 290 | PF00928 | 0.345 |
TRG_ENDOCYTIC_2 | 296 | 299 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 307 | 310 | PF00928 | 0.114 |
TRG_ENDOCYTIC_2 | 324 | 327 | PF00928 | 0.295 |
TRG_ER_diArg_1 | 187 | 190 | PF00400 | 0.344 |
TRG_ER_diArg_1 | 290 | 292 | PF00400 | 0.354 |
TRG_ER_diArg_1 | 344 | 346 | PF00400 | 0.300 |
TRG_Pf-PMV_PEXEL_1 | 152 | 156 | PF00026 | 0.343 |
TRG_Pf-PMV_PEXEL_1 | 242 | 246 | PF00026 | 0.449 |
TRG_Pf-PMV_PEXEL_1 | 35 | 39 | PF00026 | 0.412 |
TRG_PTS1 | 454 | 457 | PF00515 | 0.546 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2D6 | Leptomonas seymouri | 86% | 100% |
A0A0S4KG32 | Bodo saltans | 68% | 100% |
A0A1X0NZ36 | Trypanosomatidae | 79% | 100% |
A0A3R7RG15 | Trypanosoma rangeli | 76% | 100% |
A4H8I0 | Leishmania braziliensis | 94% | 100% |
A4HWV2 | Leishmania infantum | 100% | 100% |
C9ZPR2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 71% | 100% |
E9AQL3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q4QEW5 | Leishmania major | 98% | 100% |
Q8YSY4 | Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) | 35% | 96% |